Pharmaceutical agent for treatment of withdrawal symptoms

Details Pharmaceutical agent for treatment of withdrawal symptoms Pharmaceutical agent for treatment of withdrawal symptoms

1992-07-09

1995-01-31

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514 85, 514120, 514812, A61K 31495, A61K 31675, A61K 3166

Patent

active

053859030

ABSTRACT:
The use of the non-NMDA receptor antagonists quisqualate or kainate antagonists or their physiologically compatible salts for treatment of withdrawal symptoms after drug abuse as well as the combination of the new pharmaceutical agents with NMDA antagonists are described.

REFERENCES:
patent: 4975430 (1990-12-01), Jahr et al.
patent: 5095009 (1992-03-01), Whitten et al.
McCaslin et al., CA107(11):89773c (Chem. Abstracts) 1987.
Jpn. J. Pharmacol., vol. 55, Suppl. 1 (1991) p. 298P.
Brain Research, 552, (1991) pp. 295-300.
Akaoka, H. et al., J. of Neruorscience, Dec. 1991, vol. 11, No. 12, pp. 3830-3839.
Postgraduate Med. Journal (1988), vol. 64, (Suppl 2), pp. 40-44.

Affiliated with

Also associated with

Rating

Pharmaceutical agent for treatment of withdrawal symptoms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agent for treatment of withdrawal symptoms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agent for treatment of withdrawal symptoms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1102343